AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 84 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,406,000 | -15.5% | 1,670,000 | 0.0% | 0.21% | -9.6% |
| Q4 2021 | $13,494,000 | -39.5% | 1,670,000 | -26.6% | 0.23% | -34.3% |
| Q3 2021 | $22,295,000 | -24.1% | 2,275,000 | -47.9% | 0.35% | -31.5% |
| Q2 2021 | $29,376,000 | -25.6% | 4,365,000 | 0.0% | 0.51% | -25.0% |
| Q1 2021 | $39,460,000 | +35.3% | 4,365,000 | 0.0% | 0.68% | +35.7% |
| Q4 2020 | $29,158,000 | +37.7% | 4,365,000 | +3.9% | 0.50% | +66.8% |
| Q3 2020 | $21,168,000 | -42.6% | 4,200,000 | -8.0% | 0.30% | -58.7% |
| Q2 2020 | $36,890,000 | +6.4% | 4,565,655 | +4.6% | 0.73% | -37.7% |
| Q1 2020 | $34,663,000 | – | 4,365,655 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |